The Campbell’s Company (CPB) reported third-quarter fiscal 2026 revenues of $2,366 million, falling short of the Zacks Consensus Estimate of $2,386.51 million, resulting in a 0.9% drop in its shares. Similarly, FuelCell Energy Inc. (FCEL) experienced a significant 10.6% decline after posting second-quarter fiscal 2026 revenues of $35.59 million, below the expected $41.11 million.
In contrast, Nurix Therapeutics Inc. (NRIX) shares rose by 6.8% following its collaboration with Roche to develop and commercialize bexobrutideg. Wix.com Ltd. (WIX) saw its shares tumble 8% after revising its 2026 revenue outlook downwards due to organizational restructuring.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
